ecancer
I

ESMO 2023 Insights: "Tisotumab Vedotin vs. Investigator’s Choice of Chemo in 2L/3L Recurrent/Metastatic Cervical Cancer"

By ecancer FEATURING Ignace Vergote
By ecancer FEATURING Ignace Vergote
0 views
November 13, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

19:30
AstraZeneca Oncology

The Importance of HRD Testing in Advanced Ovarian Cancer

Feat. M. Markman

Featured Video

19:51
AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn

Recommended

AUTOPLAY
09:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future H…

Feat. E. Hamilton
27:04
Fengting Yan

Cancer Screening Molecular Tools

09:06
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

Feat. R. Salani
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
06:07
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza
04:43
Treatment Approach for Advanced Ovarian Cancer

The Role Of Folate Receptor Alpha In Ovarian Cancer

Feat. D. M. O'Malley
04:02
Total Health

2024 Updates in Cervical Cancer

Feat. T. Tillmanns
13:41
UCLA Health

2024 Updates in Locally Advanced Cervical Cancer

Feat. D. Chase
15:14
Brian Slomovitz

Update in Vulvar and Vaginal Cancer

17:20
UCLA Health

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…

Feat. G. Konecny
07:56
Fengting Yan

Year in Review: Cervical Cancer

06:41
Masonic Cancer Center, University of Minnesota

Overview of Cervical Cancer Updates

Feat. J. Mattson
05:31
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Impact of Maintenance Bevacizumab Following…

Feat. M. Kuznicki
07:03
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "innovaTV 301/ENGOT-cx12/GOG-3057 Study - Ef…

Feat. B. Slomovitz
06:46
Total Health

Recent Highlights in Cervical Cancer

Feat. B. Slomovitz
12:45
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The GCIG INTERLACE Randomised Phase 3 Tria…

Feat. M. McCormack
14:40
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "BrUOG 354 Trial Final Results - Nivo vs. …

Feat. D. Dizon
16:54
Miami Cancer Institute Precision Oncology Symposium

Precision Medicine: Management of Cervical Cancer

Feat. J. Diaz
44:59
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Updates on Cervical and Endometrial Cancers

Feat. K. Pennington
04:58
Oncology Data Advisor

Tisotumab Vedotin for Metastatic Cervical Cancer: Updates From ESMO …

Feat. B. Slomovitz